| 所在主题: | |
| 文件名: Citi China Healthcare Sector Identifying the Long-Term Leader.pdf | |
| 资料下载链接地址: https://bbs.pinggu.org/a-1161545.html | |
| 附件大小: | |
|
经常在坛子里找到各种资料,所以我也回馈一个,花旗关于国内医疗健康产业的分析报告,从医药到器械都有介绍,163页,免费送给大家,欢迎大家下载。
China Healthcare SectorHandbook Dec-2010: Identifying the Long-Term Leaders Contents National Health Expenses (NHE)5 Government Spending Driving Growth in National Health Expenses6 Central vs. Provincial Government Spending on NHE7 Medical Expenses and Costs of Hospital Visits8 Drug Costs Are a Key Component of Hospital Visits9 Hospital System10 Increase in Investments in Private Hospitals11 Government Is Upgrading the Hospital System12 Physicians and Nurses (Health Pr ofessionals) Are Clustered in Government-Owned Hospitals13 Hospital Traffic Largely Biased Towards Large Hospitals14 Hospital Traffic Largely Biased Towards Large Hospitals (cont’d)15 Hospital Visits Have Increased, Driven by Improved Healthcare Coverage16 Overall View of Medical Coverage Program17 Medical Coverage Penetration Is High, but Payout to New Rural Cooperative Program Is Low18 Medical Insurance Fund Payout Will Increase19 Demographic Shift20 China’s Population Is Aging20 Top 10 Causes of Death in China21 Increasing Incidence of Tumors22 Increase in Death Rate from Tumors23 Increasing Incidence of Chronic Circulatory Diseases and Death Rate of Cardiovascular Diseases24 sFDA’s Shift of ApprovalStandards Toward New Drugs25 Analysis of China’s Pharmaceutical Market26 China’s Hospital Drug Market27 Analysis of Market for Essential Drug List (EDL)28 Traditional Chinese Medicine (TCM) Market29 Detailed Analysis of Therapeutic Drugs31 Top 20 Drug Companies Based on Analysis of Prescription Data from 420 hospitals in 22 Major Cities34 Top 20 Hospital Drugs Based onAnalysis of Prescription Data from 420 hospitals in 22 Major Cities35 Top Therapeutic Categories and Regional Markets Based on Prescription Data from 420 Hospitals in 22 Major Cities36 Analysis of Anti-Cancer Market and Anti-Cancer Drugs39 Top-Selling Anti-Cancer Drugs by Drug Name and Manufacturers40 Top-Selling Anti-Cancer Drugs – Plant Alkaloids42 Top-Selling Anti-Cancer Drugs – Antimetabolite43 Top-Selling Anti-Cancer Drugs – Alkylating Agents44 Top-Selling Other Anti-Cancer Drugs45 Analysis of Markets for Cardiovascular Drugs46 Top-Selling Cardiovascular Drugs – by Drugs and Manufacturers47 Top-Selling Cardiovascular – Vasodilators50 Top-Selling Cardiovascular– Calcium Antagonists51 Top-Selling Cardiovascular – Angiotensins52 Top-Selling Cardiovascular – Blood-Lipid Lowering Drugs53 Top-Selling Cardiovascular – Anti-Angina Drugs54 Top-Selling Cardiovascular – Beta Blockers55 Analysis of Market for Endocrine Drugs56 Top-Selling Endocrine Drugs – by Companies57 Analysis of Diabetes Market58 Current Treatment Paradigm for Diabetes Has Many Options58 Current Insulin Market Size in China is ~Rmb3.5bn59 Insulin Market Is Dominated by Novo Nordisk60 Premixed Products Are Better Sellers in the Chinese Market61 Marketed Insulin Products in China62 Annual Costs of Insulin Ranges from Rmb1,300 to Rmb11,00063 Top-Selling Endocrine Drugs – Oral Antidiabetic64 Top-Selling Endocrine Drugs – Insulin65 Top-Selling Endocrine Drugs – Hypothalamic Hormone66 Analysis of the An tibiotics Market67 Antibiotics Is the Largest Drug Class in China’s Pharmaceutical Market67 Antibiotics Classes68 Breakdown of Antibiotics Market69 Antibiotics Drug Classes70 Antibiotics – Top-Selling Drugs71 Antibiotics – Leading Pharma Companies72 Top-Selling Antibiotics – Cephalosporin73 Top-Selling Antibiotics – Benzylpenicillin74 Top-Selling Antibiotics – Quinolone75 Top-Selling Antibiotics – Other Lactams76 Top-Selling Antibiotics – M acrolide and Lincosamides77 Top-Selling Antibiotics – Anti-Hepatitis B Drugs78 Biologics – Shining Stars with Strong Growth Potential79 Top-Selling Biologics – Monoclonal Antibodies80 Top-Selling Biologics – Recombinant Interferons81 Top-Selling Biologics – Recombinant Interleukins82 Analysis of Market for Blood and Hematopoietic System Drugs83 Top-Selling Blood and Hematopoietic System Drugs – Intravenous Infusion84 Top-Selling Blood and Hematopoietic System – Anticoagulants85 Top-Selling Blood and Hematopoietic System – Antianemic86 Analysis of Markets for Digestive System Drugs87 Top-Selling Digestive System Drugs and Manufacturers88 Top-Selling Digestive System Dr ugs – Proton Pump Inhibitor89 Top-Selling Digestive System Drugs – Hepatopathy90 Top-Selling Digestive System Drugs – Antiemetic91 Analysis of Markets for Central Nervous System Drugs92 Top-Selling Central Nervous System Drug Names93 Leading Central Nervous System Drug Companies94 Top-Selling Central Nervous System – Other Nervous System Drugs95 Top-Selling Central Nervous System Drugs – Cerebrovascular96 Top-Selling Central Nervous System Drugs – Dementia97 Top-Selling Central Nervous System Drugs – Analgesics98 Top-Selling Central Nervous System Drugs – Antiparkinsonism99 Analysis of Markets for Immunomodulator Drugs100 Top-Selling Drugs for Immunostimulant101 Top-Selling Drugs for Immunosuppressant102 Analysis of Markets for Respiratory System Drugs103 Leading Respiratory System Drug Companies104 Top-Selling Drugs for Respiratory System – Expectorant105 Top-Selling Drugs for RespiratorySystem – Antasthmatic Inhalant106 Top-Selling Drugs for Respiratory System – Antasthmatic107 Analysis of Market for Mental Disorder Drugs108 Top-Selling Mental Disorder Drugs – Antidepressant109 Top-Selling Mental Disorder Drugs – Antipsychotic Drugs110 Top-Selling Mental Disorder Drugs – Sedative111 Analysis of Markets for Urinary System Drugs112 Drug Distribution Industry113 With Multiple Layers, China’s Drug Distribution System Lacks Efficiency113 Drug Distribution Value Chain114 Industry Is Gravitating Towards Large Players115 The Pharmaceutical Markets in the US, EU and Japan Have Been Increasingly Consolidated116 Competitive Landscape in Drug Distribution118 Drugstore Overview119 China Medical Equipment and Devices120 Industry Sales y/y Growth Slowed in 2010121 Patient Monitoring Devices122 Global PMD Markets123 The U.S PMD Market124 China’s Ultrasound Market125 China’s Ultrasound Market Is Highly Competitive126 Drug-Eluting Stent Market127 Domestic Growth Rate for PCI Procedures128 More Hospitals/Doctors Will Be Able to Perform PCI surgery129 Stent Cost Accounts for Over 60% of PCI Cost130 Stent Price Cuts131 Reimbursement Policies Favor Domestic Brands132 Sales and Marketing Strategies133 Stent Market Shares by Key Players134 Overview of DES Pipeline135 Global Orthopedic Market136 Chinese Orthopedic Market137 Breakdown of Chinese Trauma and Spine Market138 Dialysis Market139 Expecting the Number of Maintenance Dialysis Patients to Grow139 Competitive Landscape in the Dialyzer Market in China140 Kidney Dialysis Is a Growing Market141 Dialysis Centers Are Getting Crowded142 China Contract Research Organization (CRO)143 Key Players and Value Chain in China’s Contract Research Organization (CRO) Market143 China vs. India – Split Opinion144 China and India CRO: Dragon vs. Elephant?145 Comparison of Outsourcing Environment for China vs. India146 Deep Dive into China’s CRO Market147 Citi Estimate of Outsourcing Ma rket in China (US$ millions)148 Toxicology Outsourcing Facing Numerous Hurdles149 Global R&D Spending Outlook150 Global R&D Spending151 Citi R&D Outsourcing Survey152 Survey Suggests That 10-20% of the Total R&D Work Is Outsourced154 Appendix A-1160 |
|
熟悉论坛请点击新手指南
|
|
| 下载说明 | |
|
1、论坛支持迅雷和网际快车等p2p多线程软件下载,请在上面选择下载通道单击右健下载即可。 2、论坛会定期自动批量更新下载地址,所以请不要浪费时间盗链论坛资源,盗链地址会很快失效。 3、本站为非盈利性质的学术交流网站,鼓励和保护原创作品,拒绝未经版权人许可的上传行为。本站如接到版权人发出的合格侵权通知,将积极的采取必要措施;同时,本站也将在技术手段和能力范围内,履行版权保护的注意义务。 (如有侵权,欢迎举报) |
|
京ICP备16021002号-2 京B2-20170662号
京公网安备 11010802022788号
论坛法律顾问:王进律师
知识产权保护声明
免责及隐私声明